Veritone has developed a proprietary artificial intelligence platform that unlocks the power of cognitive computing to transform unstructured audio and video data and analyze it in conjunction with structured data in a seamless, automated manner to generate actionable intelligence.
Yext is a knowledge engine. Their platform lets businesses manage their digital knowledge in the cloud and sync it to over 100 services, including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible.
They are a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly-applicable product candidates designed to activate a patients immune system against their own cancer from within.
They are a large scale, low-cost U.S.-based producer and exporter of premium met coal operating two highly productive underground mines in Alabama, Mine No. 4 and Mine No. 7, that have an estimated annual production capacity of 7.3 million metric tons of coal.
Credit Suisse, Citigroup, Morgan Stanley
BMO Capital Markets, RBC Capital Markets
Apollo Global Securities, Clarksons Platou Securities, KKR
They are a leading global provider of mission-critical flow control and compression equipment and associated aftermarket parts, consumables and services, which we sell across multiple attractive end-markets within the industrial, energy and medical industries.
Prior to this offering, our stock has been listed on the OTCQB Venture Market under the symbol CCGN. They strive to become a one-stop shop that focuses on financial advisory service for micro, small-to-medium sized enterprises in China.
They are a leading transportation and logistics services company providing a broad portfolio of premier truckload, intermodal and logistics solutions and operating one of the largest for-hire trucking fleets in North America.
Morgan Stanley, UBS Investment Bank
BofA Merrill Lynch, Citigroup, Credit Suisse J.P. Morgan, Wells Fargo Securities
They are a clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies that we believe can address significant unmet medical needs. Their ordinary shares are listed on the Australian Securities Exchange under the symbol IMC. On February 6, 2017, the closing price of our ordinary shares on the Australian Securities Exchange was A$0.30 per ordinary share, equivalent to $9.20 per ADS based on an exchange rate of A$1.00 to $0.7665 (as published by the Reserve Bank of Australia as of February 6, 2017).
They are the leading global provider in the rigid plastic film industry with highly complementary capabilities in semi-rigid and flexible films used in packaging and other protective film applications.